Home » 2019 » August » 06

Astellas doses first patient in phase 3 VMS trial of fezolinetant

Astellas doses first patient in phase 3 VMS trial of fezolinetant

Japanese pharma company Astellas Pharma has dosed the first patient in the SKYLIGHT 1 phase 3 trial for fezolinetant, an investigational oral, non-hormonal compound for the treatment of moderate-to-severe vasomotor symptoms (VMS) associated with menopause. Vasomotor symptoms are hot flashes and night sweats which occur in nearly 57% on women, aged 40-64 years as per […]

The post Astellas doses first patient in phase 3 VMS trial of fezolinetant appeared first on PharmaNewsDaily.com.

Aramark acquires college food delivery service Good Uncle

Aramark acquires college food delivery service Good Uncle

Aramark acquisition of Good Uncle : Aramark, a provider of food, facilities management, and uniforms, has acquired college food delivery service Good Uncle for an undisclosed price. Good Uncle is an app-based on-demand food delivery service that delivers meals that are freshly prepared and restaurant-quality to conveniently located pick-up points near college campuses. Launched in […]

Pernod Ricard to buy Texan craft whiskey distillery Firestone & Robertson

Pernod Ricard to buy Texan craft whiskey distillery Firestone & Robertson

French drinks giant Pernod Ricard, through its subsidiary Pernod Ricard USA, has agreed to acquire Texan craft whiskey distillery Firestone & Robertson Distilling, the owner of the TX whiskey brand, as per the latest drinks acquisition news. Financial terms of Pernod Ricard acquisition of Firestone & Robertson Distilling were not disclosed. The portfolio of the […]

Foamix files NDA seeking FMX103 FDA approval for rosacea

Foamix files NDA seeking FMX103 FDA approval for rosacea

Israeli pharma company Foamix Pharmaceuticals has filed a new drug application (NDA) for FMX103 to the US Food and Drug Administration (FDA) seeking FMX103 FDA approval for moderate-to-severe papulopustular rosacea in patients, aged 18 years and over. Considered to be a common skin condition, rosacea results in redness and visible blood vessels in the face. […]

The post Foamix files NDA seeking FMX103 FDA approval for rosacea appeared first on PharmaNewsDaily.com.